Article Details

Seelos Therapeutics Inc. (NASDAQ: SEEL) Announce License Agreement With iX ...

Retrieved on: 2021-12-08 07:34:23

Tags for this article:

Click the tags to see associated articles and topics

Seelos Therapeutics Inc. (NASDAQ: SEEL) Announce License Agreement With iX .... View article details on hiswai:

Excerpt

iX Biopharma will additionally receive double-digit royalties on any Licensed Product's future net sales. All funding for future development, ...

Article found on: biopharmajournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up